Dietary Intake and Nutrient Status of Children With ADHD

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title:

Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00434928
• Other study ID #: H05-70464
• Secondary ID: W05-0185
• Status: Completed
• Phase: N/A
• First received: February 13, 2007
• Last updated: February 13, 2007
• Start date: January 2006
• Est. completion date: January 2007

Study information

• Verified date: February 2007
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Observational

Clinical Trial Summary

Assess the dietary intake of children aged 6-12 years by means of a 24-hour recall and 3-day food record and asses the nutrient status of Vitamin B6, serum ferritin, serum zinc and serum copper of the same children by means of standard laboratory assessments.

Description:

• To document the use of vitamin and vitamin-mineral supplements

• To determine the percent consumption of low nutrient density (LND) foods

• To compare the dietary intake of ADHD children with the established standards of the Dietary Reference Intakes (DRIs)

• To compare the dietary intake of children with ADHD to the dietary recommendations of Canada’s Food Guide for Healthy Eating

• To determine whether dietary intake is moderated by drug treatment

• To assess the pyridoxal-5’-phosphate (PLP), serum ferritin, serum zinc, and serum copper status of ADHD by standard laboratory blood test

• to measure height and weight in ADHD children

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: January 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 6 Years to 12 Years

Eligibility

Inclusion Criteria:

• Primary diagnosis of ADHD

• Age 6-12 years inclusive

Exclusion Criteria:

• No use of medication that affects dietary intake (eg. Risperdal)

Study Design

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder
• Hyperkinesis

Locations

Country	Name	City	State
Canada	Provincial ADHD Program, BC Children's Hospital	Vancouver	British Columbia

Sponsors (2)

Lead Sponsor	Collaborator
University of British Columbia	Eli Lilly and Company

Country where clinical trial is conducted

Canada,